A New Adjuvant Treatment for Glioblastoma Using Aprepitant, Vortioxetine, Roflumilast and Olanzapine: The AVRO Regimen. [PDF]
Int J Mol SciKast RE +2 more
europepmc +1 more source
Clinical guidelines highlight for the hospitalist: Management of cyclic vomiting syndrome in children. [PDF]
J Hosp MedHernandez YN, Gardner HM.
europepmc +1 more source
Do Not Throw Away Your Patient's Shot at Complete Vomiting Control. [PDF]
J Pediatr Pharmacol TherDupuis LL, Patel P.
europepmc +1 more source
Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]
CureusSarma I +7 more
europepmc +1 more source
Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review. [PDF]
Curr Oncol RepIimura Y, Kuroda S.
europepmc +1 more source
Evidence-Based Perioperative Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Laparoscopic Bariatric Surgery: A Scoping Review. [PDF]
J Clin MedMieszczański P +4 more
europepmc +1 more source
Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched Study. [PDF]
Cancer Manag ResMaeda K +13 more
europepmc +1 more source
Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]
Support Care CancerTokito Y +10 more
europepmc +1 more source
Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer. [PDF]
Sci RepGhahremanloo A +5 more
europepmc +1 more source